BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.6 CNY | +0.52% |
|
-2.34% | -19.87% |
| May. 06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
| Apr. 26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Evolution of the average Target Price on Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
73fae04ce8846660bc.sQqQtd4jEee4JzW2RYXr3ESNGwTbbas0ViXIeSMC-7E.nHPS0ohUdJbOaxjzcMGThRLbKkyBWsBYe3KENRBsvIf8WePz8xpbktR2ZA~f5c32474dc2801305febf0d5f35c3e33
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.906
CNY
Average target price
14.21
CNY
Spread / Average Target
+59.61%
High Price Target
15.02
CNY
Spread / Highest target
+68.61%
Low Price Target
13.41
CNY
Spread / Lowest Target
+50.61%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2315 Stock
- Consensus Biocytogen Pharmaceuticals (Beijing) Co., Ltd.